Assessment of the safety of long-acting β2-agonists in routine asthma care: the ASTRO-LAB protocol
- PMID: 26086323
- PMCID: PMC4498225
- DOI: 10.1038/npjpcrm.2015.40
Assessment of the safety of long-acting β2-agonists in routine asthma care: the ASTRO-LAB protocol
Figures
References
-
- Chowdhury BA, Dal Pan G. The FDA and safe use of long-acting beta-agonists in the treatment of asthma. N Engl J Med. 2010;362:1169–1171. - PubMed
-
- Cates CJ, Jaeschke R, Schmidt S, Ferrer M. Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events. Cochrane Database Syst Rev. 2013;3:CD006922. - PubMed
-
- Cates CJ, Jaeschke R, Schmidt S, Ferrer M. Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events. Cochrane Database Syst Rev. 2013;6:CD006924. - PubMed
-
- Strom BL. Pharmacoepidemiology. John Wiley & Sons Ltd; 2008. pp. 1–889.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous